Brian C. Bock joined COUR in 2022 as chief financial officer where he oversees the finance, accounting, and administration departments; and is responsible for raising capital, financial planning, and corporate strategy.

Prior to joining COUR, Brian served as CFO and subsequently CEO of Exicure, Inc, a publicly traded biotechnology company, which he joined in May of 2021. Previously, he served as Managing Director, Healthcare Investment Banking at Lincoln International, where he led the firm’s investment banking advisory engagements with life science companies. Brian’s extensive history includes advising and working with early- to late-stage healthcare companies, public institutional investors, and venture capital and private equity firms. Prior to Lincoln, Brian served as Managing Director, Healthcare Investment Banking at JMP Securities and was a member of the Healthcare Investment Banking team at RBC Capital Markets.

Brian received his Bachelor of Science in Finance from Northern Arizona University.

• 

  CFO: Chief Financial Officer in COUR Pharmaceuticals

  First-In-Class Therapies Designed to Reprogram the Immune System